je.st
news
RPT-Gilead to raise price for new hepatitis C drug above $84,000
2014-09-13 15:27:46| Biotech - Topix.net
The next generation version of Gilead Sciences Inc's $84,000 hepatitis C drug, already under fire for its record-breaking costs, is going to be even more expensive. Gregg Alton, Gilead's executive vice president of corporate and medical affairs, declined to give an exact price for the new medicine, the first all-oral treatment for the virus which is expected to launch next month.
Tags: price
drug
raise
hepatitis
Category:Biotechnology and Pharmaceuticals